Subclinical Hypothyroidism Affects Mitochondrial Function

Abstract

The aim of the present study was to examine mitochondrial function in cells from persons with subclinical hypothyroidism and euthyroid controls. The participating persons were examined clinically and had basal oxygen consumption (VO₂) determined. The concentrations of thyroid hormones and thyrotropine stimulating hormone were determined, and mitochondrial function in isolated mononuclear blood cells was examined by enzymatic methods [citrate synthase activity (CS)] and by flow cytometry (mitochondrial membrane potential by TMRM fluorescence and mitochondrial mass by MTG fluorescence). The ratio of T₄/T₃ was lowered in subclinical hypothyroidism patients compared to controls (2.5±0.5 vs. 2.9±0.4, p=0.005). VO₂ was increased in persons with subclinical hypothyroidism compared to controls (adolescents: 134±27 ml O₂/min*m² vs. 119±27 ml O₂/min*m², p=0.006, adults: 139±14 ml O₂/min*m² vs. 121±17 ml O₂/min*m², p=0.001). The mitochondrial function, represented by citrate synthase activity, MTG, and TMRM fluorescence were all increased (CS in subclinical hypothyroidism vs. controls: 0.074±0.044 nmol/mg*min vs. 0.056±0.021 nmol/mg*min, p=0.005; MTG fluorescence in subclinical hypothyroidism vs. controls: 7 482±1 733 a.u. vs. 6 391±2 171 a.u., p=0.027; TMRM fluorescence in subclinical hypothyroidism vs. controls: 1 3449±3 807 a.u. vs. 1 1733±4 473 a.u, p=0.04). Our results indicate an increased mitochondrial stimulation, eventually caused by increased deiodination of T₄ to intracellular bioactive iodothyronines in adults and adolescents with subclinical hypothyroidism.

Key words

hyperthyroidism - subclinical hyperthyroidism - thyroid function - thyroid hormones

References

• 1 Biondi B, Cooper D. The clinical significance of subclinical thyroid dysfunction.  Endocrine Rev. 2007;  10 1-236
• 2 Kvetny J, Heldgaard PE, Bladbjerg E-M, Gram J. Subclinical hypothyroidism is associated with a lowgrade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years.  Clin Endocrinol. 2004;  61 232-238
• 3 Hak AE, Pols HAP, Visser TJ, Drexhage HE, Hofman A, Witteamn JCM. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: The Rotterdam Study.  Arch Intern Med. 2000;  132 270-278
• 4 Weitzel J, Iwen K, Seitz H. Regulation of mitochondrial biogenesis by thyroid hormone.  Exp Physiol. 2003;  88 121-128
• 5 Kvetny J. 3,5-T2 stimulates oxygen consumption, but not glucose uptake in human mononuclear blood cells.  Horm Metab Res. 1992;  24 322-325
• 6 Kvetny J, Bomholt T, Pedersen P, Wilms L, Anthonsen S, Larsen J. Thyroid hormone effect on human mitochondria measured by flow cytometry.  Scand J Clin Lab Invest. 2009;  69 772-776
• 7 Huang H, Fowler C, Xu H, Zhang H, Gibson G. Mitochondrial function in fibroblasts with aging in culture and/or Alzheimer's disease.  Neurobiol Aging. 2005;  26 838-848
• 8 Poot M, Pierce R. Analysis of Mitochondria by Flow Cytometry.. In: Darzynkiewicz Z, Crissman H, Robinson J (eds). Cytometry. Methods in Cell Biology. New York: Academic Press; 2001: 117-128
• 9 Plasek J, Vojtiskova A, Houstek J. Flow-cytometric monitoring of mitochondrial depolarisation:from fluorescence intensities to millivolts.  J Photochem Photobiol. 2005;  78 99-108
• 10 Knudsen N, Jørgensen T, Rasmussen S, Christiansen E, Perrild H. The prevalence of thyroid dysfunction in a population with borderline iodine deficiency.  Clin Endocrinol. 1999;  51 361-367
• 11 Vejbjerg P, Knudsen N, Perrild H, Laurberg P, Carlé A, Andersen I, Rasmussen L, Ovesen L, Jørgensen T. Lower prevalence of mild hyperthyroidism related to a higher iodine intake in the population: prospective study of a mandatory iodization programme.  Clin Endocrinol. 2009;  71 440-445
• 12 Moura E, Santos R, Lisboa P, Alves S, Bonomo I, Fagundes A, Oliveira E, Passos M. Thyroid Function and Body Weight Programming by Neonatal Hyperthyroidism in Rats – The Role of Leptin and Deiodinase Activities.  Horm Metab Res. 2008;  40 1-7
• 13 Kvetny J. The significance of clinical euthyroidism on reference range for thyroid hormones.  Eur J Int Med. 2003;  14 315-320
• 14 Kvetny J. Subclinical hyperthyroidism in patients with nodular goiter represents a hypermetabolic state.  Exp Clin Endocrinol Diab. 2005;  113 1-5
• 15 Lebon V, Dufour S, Petersen K, Ren J, Jucker B, Slezak L, Cline G, Rothman D, Shulman G. Effect of triiodothyronine on mitochondrial energy coupling in human skeletal muscle.  J Clin Invest. 2001;  108 733-737
• 16 Pendergrass W, Wolf N, Poot M. Efficacy of MitoTracker Green™ and CMXRosamine to measure changes in mitochondrial membrane potentials in living cells and tissues.  Cytometry. 2004;  A 162-169
• 17 Venditti S, De Meo S. Thyroid hormone-induced oxidative stress.  Cell Mol Life Sci. 2006;  63 414-434
• 18 Madamanchi N, Vendrov A, Runge M. Oxidative stress and vascular disease.  Arterioscler Thromb Vasc Biol. 2005;  25 29-38
• 19 Teixeira P, Reuters P, Ferreira P, Almeida C, Reiss F, Melo B, Buescu A, Costa A, Vaisman M. Treatment of subclinical hypothyroidism reduces atherogenic lipid levels in a placebo-controlled double-blind clinical trial.  Horm Metab Res. 2008;  40 50-55
• 20 Chan B, Gartland A, Wilson P, Buckley K, Dillon J, Fraser W, Gallagher J. PPAR agonists modulate human osteoclast formation and activity in vitro.  Bone. 2007;  40 149-159
• 21 Solaini G, Sgarbi G, Lenaz G, Baracca A. Evaluating mitochondrial membrane potential in cells.  Biosci Rep. 2007;  27 11-21

Correspondence